Skip to main content

Table 1 Characteristics of the publications included in the meta-analysis by source and type of polyunsaturated fatty acid (PUFA)

From: Impact of type and dose of oral polyunsaturated fatty acid supplementation on disease activity in inflammatory rheumatic diseases: a systematic literature review and meta-analysis

Study

Disease

No. of participants

PUFA source

PUFA dose (g/day)

Control

Duration (weeks)

Jadad score

Measures

PUFA

Total

 

EPA

DHA

DPA

ALA

Total n-3 intake

GLA

Total n-6 intake

    

Araujo 2014 [20]

RA

11

37

Fish oil

       

Not mentioned

24

Abstract

TJ, SJ, activity, DAS28, CRP, ESR

Berbert 2005 [21]

RA

30

43

Fish oil

    

3

  

Soy oil

24

2

MS, pain, activity, CRP, ESR

Brzeski 1991 [22]

RA

19

40

Vegetable oil

     

0.5

0.5

Olive oil capsules

24

3

TJ, MS, pain

Cleland 1988 [23]

RA

23

23

Fish oil

    

5.2

  

Olive oil capsules

12

4

TJ, SJ, MS, pain

Das Gupta 2009 [24]

RA

50

100

Fish oil

    

3

  

No special diet or intervention

12

1

TJ, SJ, pain, DAS28, CRP, ESR

Dawczynski 2009 [25]

RA

14

26

Fish oil

0.7

0.4

0.1

1.1

2.3

  

Dairy with comparable fat content

24

3

TJ, SJ, DAS28, CRP, ESR

Dawczynski 2011 [26]

PsA+RA

14

47

Fish oil

    

3.0

  

Olive oil capsules

12

4

DAS28

Dawczynski 2018 [27]

RA

25

25

Fish oil

 

2.1

  

2.1

  

Sunflower oil capsules

10

3

TJ, SJ, DAS28, CRP, ESR

Galarraga 2008 [28]

RA

49

97

Fish oil

1.5

0.7

  

2.2

  

Air-filled capsules

36

4

Pain, DAS28, CRP, HAQ

Geusens 1994 [29]

RA

21

60

Fish oil

    

1.3

  

Olive oil capsules

48

3

TJ, pain, activity

19

    

2.6

  

Khaleghi 2005 [30]

RA

10

39

Fish oil

    

10

  

Corn oil

8

Abstract

TJ, SJ

Kolahi 2010 [31]

RA

40

83

Fish oil

0.2

0.1

  

0.3

  

Capsules without n-3 PUFAs

24

3

DAS28, CRP

Kremer 1990 [32]

RA

20

49

Fish oil

1.9

1.3

  

3.2

  

Olive oil capsules

24

2

TJ, SJ, MS, pain, activity

17

3.8

2.5

  

6.3

  

Kremer 1995 [33]

RA

23

49

Fish oil

    

9.1

  

Corn oil capsules

30

2

TJ, SJ, MS, pain, activity

Kremer 1985 [34]

RA

23

44

Fish oil

1.7

1.1

  

2.8

  

Diet low in PUFA/SFA plus paraffin capsules

12

4

TJ, SJ, MS

Kristensen 2018 [35]

PsA

72

143

Fish oil

1.5

1.5

  

3.0

  

Olive oil capsules

24

5

TJ, SJ, pain, DAS28, HAQ

Leventhal 1993 [36]

RA

19

37

Vegetable oil

     

1.4

1.4

Cottonseed oil capsules

24

2

TJ, SJ, MS, pain, activity, ESR

Madland 2006 [37]

PsA

20

40

Fish oil

2.4

2.6

1.1

 

6.1

  

Soil oil capsules

0.5

2

TJ, SJ, pain, activity, ESR, HAQ

Magaro 1992 [38]

RA

10

20

Fish oil

1.5

1.0

  

2.5

  

No special diet or intervention

6

1

MS, pain, ESR

Nielsen 1992 [39]

RA

29

57

Fish oil

2.0

1.2

  

3.2

  

Capsules with fat composition as the average Danish diet

12

4

TJ, SJ, CRP, ESR

Nordström 1995 [40]

RA

11

22

Vegetable oil

   

9.6

9.6

  

Safflower oil

24

2

TJ, pain, activity, CRP, ESR

Park 2013 [41]

RA

41

81

Fish oil

2.1

1.2

  

3.3

  

Sunflower oil with oleic acid capsules

16

2

Pain, activity, CRP, HAQ

Skoldstam 1992 [42]

RA

22

46

Fish oil

1.7

1.1

  

2.8

  

Maize/olive/peppermint oil capsules

24

4

Pain, activity, CRP, ESR

Sundrarjun 2004 [43]

RA

23

60

Fish oil

    

3.4

  

Diet low in PUFA plus placebo capsules

24

3

TJ, SJ, pain, activity, CRP, ESR, HAQ

Sundström 2006 [44]

AS

9

18

Fish oil

    

1.9

  

Low dose vs high dose

21

1

ESR

Tulleken 1990 [45]

RA

12

24

Fish oil

2.0

 

1.3

 

3.3

  

Coconut oil capsules

24

4

TJ, SJ, pain, CRP, ESR

Veale 1994 [46]

PsA

19

38

Mix oil

0.2

0.1

  

0.3

0.5

0.5

Liquid paraffin and vitamin E capsules

36

2

TJ

Veselinovic 2017 [47]

RA

20

60

Fish oil

1.0

1.5

  

2.5

  

No special diet or intervention

12

2

TJ, SJ, pain, DAS28, CRP, ESR

Volker 2000 [48]

RA

13

26

Fish oil

    

1.7

  

Diet low in u-6 PUFAs plus corn and olive oil

15

3

TJ, SJ, pain, activity, CRP, ESR, HAQ

Zurier 1996 [49]

RA

28

56

Vegetable oil

     

2.8

2.8

Sunflower seed oil

24

4

TJ, SJ, MS, pain, activity, HAQ

  1. EPA eicosapentaenoic acid (C20:5n3), DHA docosahexaenoic acid (C22:6n3), DPA docosapentaenoic acid (C22:5n3), ALA linolenic acid (C18:3n3), GLA gamma-linolenic acid (C18:3n6), n-3 omega-3, n-6 omega-6, PUFA polyunsaturated fatty acid, EPO evening primrose oil, RA rheumatoid arthritis, PsA psoriatic arthritis, AS ankylosing spondylitis, activity patient activity on visual analog scale, CRP C-reactive protein, DAS Disease Activity Score, ESR erythrocyte sedimentation rate, HAQ Health Assessment Questionnaire, MS morning stiffness, NSAID non-steroidal anti-inflammatory drug, SJ swollen joint count, TJ tender joint count